Product Overview
The Clotalyst Autologous Activation System rapidly produces up to 10 ml of autologous clotting factors from 12 ml of the patient’s blood at the point-of-care. When combined with the leukocyte-rich platelet–rich plasma (L-PRP) produced by the GPS III Platelet Concentration System, the autologous clotting factors from the Clotalyst Autologous Activation System activate platelets and initiate fibrin formation and cross-linking to form a platelet gel in under 15 seconds.
Zimmer Biomet Biologics has re-designed the Clotalyst® Autologous Serum System to the new and improved Clotalyst® Autologous Activation System. The key features of the new design include:
Autologous Activation Solution
• No pooled or bovine sources
• Eliminates risk of bovine spongiform encephalopathy (BSE)
• Eliminates potential source related coagulopathies
User-Friendly
• Minimal steps required for processing
• No heating step required
• No centrifugation step required
Reliable
• Consistently produces up to 10 ml of activation solution
• Clots platelet-rich plasma in less than 15 seconds
• Activation solution stable up to four hours after preparation
Convenient Design
• Single use disposable device
• No additional mechanical processing required
• Total processing time of less than 20 minutes
(https://www.zimmerbiomet.com)
